Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: STEMCELL TECHNOLOGIES INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-08-15 to 2024-01-29
Current total value of award: $29353.5
Description: ANTIVIRALS FOR NEUROTROPIC VIRUSES OF PANDEMIC POTENTIAL